Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01074008
What this trial is testing

Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 74
Not applicableUnknownNCT04768517
What this trial is testing

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus (HIV) Coinfection
National Taiwan University Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Post-approval studies (Phase 4)WithdrawnNCT03623568
What this trial is testing

Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant

Who this might be right for
Kidney FailureKidney DiseasesHepatitis C
Raymond T. Chung, MD
Not applicableStudy completedNCT00002186
What this trial is testing

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals 400
Testing effectiveness (Phase 2)Study completedNCT01825980
What this trial is testing

Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C
Novartis Pharmaceuticals 54
Testing effectiveness (Phase 2)Study completedNCT06039579
What this trial is testing

Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
ViiV Healthcare 44
Not applicableStudy completedNCT00001111
What this trial is testing

Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 35
Large-scale testing (Phase 3)Study completedNCT04990830
What this trial is testing

Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeHypoxemia
Istanbul University 80
Post-approval studies (Phase 4)Ended earlyNCT03208244
What this trial is testing

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant

Who this might be right for
End Stage Heart DiseaseHepatitis C
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00743795
What this trial is testing

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 252
Post-approval studies (Phase 4)Looking for participantsNCT05626530
What this trial is testing

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionsInfection in Solid Organ Transplant RecipientsNeutropenia+1 more
Tufts Medical Center 25
Large-scale testing (Phase 3)Ended earlyNCT00447902
What this trial is testing

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Who this might be right for
HIV Infections
Boehringer Ingelheim 11
Not applicableStudy completedNCT04264312
What this trial is testing

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

Who this might be right for
Hepatitis B
Wu Jiang 76,220
Testing effectiveness (Phase 2)Study completedNCT00867139
What this trial is testing

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Who this might be right for
Influenza
Fred Hutchinson Cancer Center 7
Not applicableStudy completedNCT03566966
What this trial is testing

Autoantibodies and Direct-acting Antivirals

Who this might be right for
Viral Hepatitis CTherapy Adverse Effect
University of Bari 191
Large-scale testing (Phase 3)UnknownNCT05172037
What this trial is testing

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Who this might be right for
Covid19
Genova Inc. 222
Not applicableNot Yet RecruitingNCT07274345
What this trial is testing

Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients

Who this might be right for
Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection
Amira Mohamed Zidan 2,000
Testing effectiveness (Phase 2)Study completedNCT04918927
What this trial is testing

Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19

Who this might be right for
Covid19
Coordinación de Investigación en Salud, Mexico 120
Testing effectiveness (Phase 2)WithdrawnNCT00051077
What this trial is testing

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis BHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Next Page